A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) up to 16 ...

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) face a more than threefold increased risk of preterm birth, according to a new population-based study conducted by ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

The findings, published in BMC Oral Health, suggest that incorporating routine oral health assessments into the management of ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Discover a study presented at EASL 2025 that found that timely public health policies can reduce the global burden of MASLD.

Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide.

Bariatric surgery and GLP-1s conferred similar outcomes in mortality, adverse cardiovascular events and cirrhosis development ...